298 results
8-K
EX-99.1
CRDF
Cardiff Oncology Inc
2 May 24
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
4:10pm
-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 … and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations
8-K
EX-99.2
CRDF
Cardiff Oncology Inc
29 Feb 24
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:08pm
Securities Litigation Reform Act of 1995. These statements may be identified using words such as "anticipate," "believe," "forecast," "estimated … and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations
8-K
EX-99.1
CRDF
Cardiff Oncology Inc
29 Feb 24
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:08pm
Litigation Reform Act of 1995. These statements may be identified using words such as "anticipate," "believe," "forecast," "estimated" and "intend … and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations
8-K
EX-99.4
CRDF
Cardiff Oncology Inc
29 Feb 24
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:08pm
competition; uncertainties of patent protection and litigation; dependence upon third parties; and risks related to failure to obtain FDA clearances
8-K
EX-99.3
ni6c q2j2
29 Feb 24
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
4:08pm
8-K
EX-99.1
gllbjl
2 Nov 23
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
4:06pm
8-K
EX-99.2
m0zz7s 94a9
2 Nov 23
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
4:06pm
8-K
EX-99.2
24w jlyyvzaqzaei4n
26 Sep 23
Pancreatic Cancer and Small Cell Lung Cancer Program Updates
4:07pm
8-K
EX-99.1
fnuayh2 9ltgs5qxn
9 Aug 23
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
4:06pm
8-K
EX-99.2
l3x2smv3jo
7 Aug 23
AU GU ST 7 , 2 0 2 3 mCRC Program Update and Clinical Development Plan
4:42pm
8-K
EX-99.1
pp9pmb3bruludl
4 May 23
Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
4:01pm
8-K
EX-99.1
c1i4l0mlv0s si0yk
3 Nov 22
Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
4:14pm
8-K
EX-99.3
bzpsn9a45ak1su
12 Sep 22
Regulation FD Disclosure
4:09pm